Bone and Soft Tissue Tumor Program
Bone and soft tissue tumors are complex and can be difficult to diagnose. There are also many treatment options available, and some children will need a combination of these therapies. Whether your child has a benign tumor or malignant tumor (also called a sarcoma), or you’re seeking a second opinion after a recent diagnosis, the experts at the Bone and Soft Tissue Tumor Program at Children's Hospital of Philadelphia (CHOP) will provide your family with personalized care.
Our team approach to treatment means specialists from several areas collaborate in the care of each and every patient to provide your family with the best possible outcome.
Ewing Sarcoma: Sean’s Story
Sean’s dream of becoming a kicker was put on hold, temporarily. Precision treatment for Ewing sarcoma put him back on the field, where he can one day make his dream a reality.
Why Choose Us?
Patients and families treated through our multidisciplinary Bone and Soft Tissue Tumor Program have access to a team of pioneering surgeons, state-of-the-art molecular profiling, and an extensive array of treatment options, all customized to meet your child’s specific needs. The program is a unique collaboration between two world-class pediatric programs: the Division of Orthopaedics and the Cancer Center. Both programs are consistently ranked among the best in the nation by U.S. News & World Report’s Honor Roll of Best Children’s Hospitals. When making decisions about your child’s treatment, consider these factors.
Conditions We Treat
Our Programs and Services
Our Team
Your child’s care team may include experts from several areas of medicine, including pediatric orthopaedic surgery, oncology, diagnostic and interventional radiology, radiation oncology and more.
